iBio, Inc. Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018 - 2009
Revenue	0	1.88	2.37	1.64	2.02	Upgrade
Revenue Growth (YoY)	-	-20.54%	44.75%	-18.83%	354.50%	Upgrade
Cost of Revenue	0	0	1.46	0.7	0	Upgrade
Gross Profit	0	1.88	0.91	0.94	2.02	Upgrade
Selling, General & Admin	19.02	21.75	22.03	11.37	12.33	Upgrade
Research & Development	10.33	9.83	9.99	3.57	5.47	Upgrade
Operating Expenses	29.34	31.58	32.02	14.94	17.81	Upgrade
Operating Income	-29.34	-29.7	-31.11	-14	-15.79	Upgrade
Interest Expense / Income	0.08	0	2.45	2.47	1.9	Upgrade
Other Expense / Income	35.58	20.69	-10.36	-0.03	-0.1	Upgrade
Pretax Income	-65.01	-50.39	-23.21	-16.44	-17.59	Upgrade
Net Income	-65.01	-50.39	-23.21	-16.44	-17.59	Upgrade
Preferred Dividends	0	0	0.26	21.82	0.26	Upgrade
Net Income Common	-65.01	-50.39	-23.47	-38.26	-17.85	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change	40.41%	11.45%	211.53%	231.79%	78.03%	Upgrade
EPS (Basic)	-106.20	-115.60	-60.00	-305.00	-470.00	Upgrade
EPS (Diluted)	-106.20	-115.60	-60.00	-305.00	-470.00	Upgrade
Free Cash Flow	-33.57	-49.11	-35.23	-14.5	-14.97	Upgrade
Free Cash Flow Per Share	-54.84	-112.63	-90.03	-115.45	-395.36	Upgrade
Gross Margin	-	100.00%	38.34%	57.08%	100.00%	Upgrade
Operating Margin	-	-1576.27%	-1312.15%	-854.88%	-782.36%	Upgrade
Profit Margin	-	-2674.68%	-989.75%	-2335.78%	-884.69%	Upgrade
Free Cash Flow Margin	-	-2606.69%	-1485.70%	-885.16%	-741.58%	Upgrade
EBITDA	-63.55	-46.6	-18.34	-11.73	-13.94	Upgrade
EBITDA Margin	-	-2473.46%	-773.47%	-716.24%	-690.98%	Upgrade
Depreciation & Amortization	1.38	3.79	2.41	2.24	1.75	Upgrade
EBIT	-64.93	-50.39	-20.75	-13.97	-15.69	Upgrade
EBIT Margin	-	-2674.68%	-875.28%	-853.05%	-777.65%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).